Developing AI tools to predict how T cells recognize cancer antigens
Official title: MATCHMAKERS - Creating and training AI tools for TCR binding prediction and design
Funded at Massachusetts Institute of Technology · NIH-11045160 · Data updated 2026-11-12
This study is exploring how our immune system's T cells recognize cancer markers, using smart computer techniques to help develop better treatments that specifically target tumors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | May 1, 2024 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $681,176 |
| NIH project number | 1OT2CA297463-01 |
| Project ID | NIH-11045160 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with malignant neoplasms who may benefit from targeted immunotherapy.
✕Less likely to help
Patients with non-malignant conditions or those not eligible for immunotherapy may not receive benefits from this research.
What this research studies
This research focuses on understanding how T cell receptors (TCRs) identify tumor antigens presented by major histocompatibility complexes (MHCs). By combining advanced machine learning techniques with extensive data on TCR-pMHC pairs, the project aims to create accurate predictive models for TCR-antigen recognition. The research involves generating large datasets from both human and mouse sources and utilizing synthetic approaches to enhance TCR matching. This could lead to improved antigen-specific immunotherapies for cancer treatment.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer immunotherapies.
How similar studies have gone: Other research has shown promise in using machine learning for predicting TCR interactions, indicating a potential for success in this novel approach.
Where this research is happening
-
Massachusetts Institute of Technology
Cambridge, United States Active
Researchers
- Principal investigator: Birnbaum, Michael — Massachusetts Institute of Technology
- Study coordinator: Birnbaum, Michael
Related research
Other NIH-funded projects on the same topics.
-
PhysioNet: A trusted, open data repository for clinical and physiological data
A publicly accessible platform provides curated clinical and physiological data and tools to help researchers develop and test AI models for better healthcare.
-
Dormancy in Triple-Negative Breast Cancer: How Liver and Skin Metastases Go Quiet or Reactivate
Researchers will study how dormant cancer cells in liver and skin metastases of triple-negative breast cancer become quiescent or wake up, using organ-on-chip models and single-cell analysis to map chromatin states.
-
Single-cell, label-free mapping of senescence in tissues with Raman imaging and spatial genomics
A project to map how senescent cells differ across tissues using a noninvasive Raman imaging method combined with spatial genomics.
-
Structures and dynamics of virus ion channels
This project studies the tiny channels in certain influenza and coronavirus viruses to understand how they let ions pass through and contribute to disease.
-
Prospect: Stem Cell Models for Early-Onset Colorectal Cancer Prevention
Researchers at MIT are using stem cell models to understand why colorectal cancer is rising in people under 50 and how to prevent it.
-
MATCHMAKERS: AI tools to predict TCR binding and design
Researchers are building AI tools to predict how T cell receptors recognize tumor antigens, with aims to help improve targeted immunotherapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.